Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials-Reference-Cited by-同舟云学术

Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials

Published:2012-03-16 Issue:6 Volume:101 Page:461-467
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

de Waha Antoinette,Cassese Salvatore,Park Duk-Woo,Burzotta Francesco,Byrne Robert A.,Tada Tomohisa,King Lamin A.,Park Seung-Jung,Schömig Albert,Kastrati Adnan

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-012-0414-8.pdf

Reference31 articles.

1. Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker T, Senges J (2007) The sirolimus-eluting coronary stent in daily routine practice in germany: trends in indications over the years. Results from the prospective multi-centre german cypher stent registry. Clin Res Cardiol 96:548–556

2. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A (2007) Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356:1030–1039

3. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Juni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937–948

4. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356:998–1008

5. de Waha A, Dibra A, Kufner S, Baumgart D, Sabate M, Maresta A, Schömig A, Kastrati A (2011) Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with diabetes mellitus: a patient-level meta-analysis of randomized trials. Clin Res Cardiol 100:561–570

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-hospital and 1-Year Outcomes of Repeated Percutaneous Coronary Intervention for In-stent Restenosis With Acute Coronary Syndrome Presentation;Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine;2022-03-03

2. Angiographic performance of everolimus‐eluting stents for the treatment of coronary in‐stent restenosis in daily practice;Catheterization and Cardiovascular Interventions;2020-08-26

3. Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease;Journal of the American College of Cardiology;2019-10

4. Comparison of extraction methods of sirolimus from polymeric coatings of bioresorbable vascular scaffolds;Materials Letters;2018-03

5. Differences of Chronic Angioscopic Findings among Stent Types in Patients with or without Diabetes Mellitus: Sub-Analysis of a Japanese Multicenter Registry Study (MICASA);Angioscopy;2017